PENICILLIN V HYDRABAMINE, a semi-synthetic antibiotic, is used for the treatment of mild to moderately severe infections (e.g. dental infection, infections in the heart, middle ear infections, rheumatic fever, scarlet fever, skin infections, upper and lower respiratory tract infections) caused by susceptible, usually gram-positive, organisms.

PENICILLIN G HYDRABAMINE, a semi-synthetic antibiotic, is used for the treatment of infections caused by susceptible, usually gram-positive, organisms.

Contulakin-G is the synthetic form of a natural peptide extracted from the venom of the Conus Geographus sea snail that used in animal models as a broad-spectrum non-opioid analgesic. Contulakin-G was previously shown to be an agonist for all three subtypes of neurotensin receptors, NTS1, NTS2, and NTS3 with submicromolar potency. Contulakin-G exhibited potent analgesic activity in three pain models in rats following intrathecal delivery, namely in tail-flick (acute pain), formalin test, and CFA-induced allodynia inflammatory pain. Contulakin-G (coded as CGX-1160) was granted an orphan drug designation by the US Food and Drug Administration (FDA) and reached a clinical development stage for the treatment of chronic intractable pain following intrathecal administration in patients with spinal cord injury